Abstract
Two-dimensional electrophoresis has, for many years, been the primary workhorse for performing functional proteomics, the large-scale analysis of protein expression differences. Despite its merits, limitations inherent to this technology have been recognized for a long time, ranging from its gel-to-gel variability to its inability to represent several classes of proteins. Recently, however, technical advances in two-dimensional electrophoresis have alleviated several of these drawbacks. Fractionation approaches prior to two-dimensional electrophoresis, e.g. by chromatography, organelle fractionation or Equalizer Beads technology, have increased the number of visible proteins. Fluorescent two-dimensional difference gel electrophoresis has boosted the quantitative aspects of two-dimensional electrophoresis. New protein stains have also enabled the analysis of post-translationally modified proteins. As a result, two-dimensional electrophoresis has been thoroughly modernized, enabling it to remain the preferred method for protein expression analysis in a large number of laboratories. In this review we will give an overview of these technological advances.
Keywords: Two-dimensionalelectrophoresis, Proteomics, Phosphorylation, Glycosylation, 2-D DIGE, Protein prefractionation
Current Analytical Chemistry
Title: High Resolution Protein Display by Two-Dimensional Electrophoresis
Volume: 5 Issue: 2
Author(s): Gert Van den Bergh and Lutgarde Arckens
Affiliation:
Keywords: Two-dimensionalelectrophoresis, Proteomics, Phosphorylation, Glycosylation, 2-D DIGE, Protein prefractionation
Abstract: Two-dimensional electrophoresis has, for many years, been the primary workhorse for performing functional proteomics, the large-scale analysis of protein expression differences. Despite its merits, limitations inherent to this technology have been recognized for a long time, ranging from its gel-to-gel variability to its inability to represent several classes of proteins. Recently, however, technical advances in two-dimensional electrophoresis have alleviated several of these drawbacks. Fractionation approaches prior to two-dimensional electrophoresis, e.g. by chromatography, organelle fractionation or Equalizer Beads technology, have increased the number of visible proteins. Fluorescent two-dimensional difference gel electrophoresis has boosted the quantitative aspects of two-dimensional electrophoresis. New protein stains have also enabled the analysis of post-translationally modified proteins. As a result, two-dimensional electrophoresis has been thoroughly modernized, enabling it to remain the preferred method for protein expression analysis in a large number of laboratories. In this review we will give an overview of these technological advances.
Export Options
About this article
Cite this article as:
Bergh Van den Gert and Arckens Lutgarde, High Resolution Protein Display by Two-Dimensional Electrophoresis, Current Analytical Chemistry 2009; 5 (2) . https://dx.doi.org/10.2174/157341109787846199
DOI https://dx.doi.org/10.2174/157341109787846199 |
Print ISSN 1573-4110 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6727 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
FLT3 Inhibitors in the Management of Acute Myeloid Leukemia
Anti-Cancer Agents in Medicinal Chemistry Nucleic Acid-Based Aptamers: Applications, Development and Clinical Trials
Current Medicinal Chemistry Malignant Mesothelioma: Biology, Diagnosis and Therapeutic Approaches
Current Molecular Pharmacology MicroRNAs: Key Players in Microglia and Astrocyte Mediated Inflammation in CNS Pathologies
Current Medicinal Chemistry QSAR and Molecular Modeling Studies on a Series of Indole-based Pyridone Analogues as HCV NS5B Polymerase Inhibitors
Letters in Drug Design & Discovery Second Generation Proteasome Inhibitors in Multiple Myeloma
Anti-Cancer Agents in Medicinal Chemistry Topoisomerase I and II Inhibitors: A Patent Review
Recent Patents on Anti-Cancer Drug Discovery Anticarcinogenic Actions of Tributyrin, A Butyric Acid Prodrug
Current Drug Targets Therapeutic Strategy of Advanced Hepatocellular Carcinoma by Using Combined Intra-Arterial Chemotherapy
Recent Patents on Anti-Cancer Drug Discovery E2F1-Mediated Apoptosis as a Target of Cancer Therapy
Current Molecular Pharmacology Radiolabelled Regulatory Peptides for Imaging and Therapy
Anti-Cancer Agents in Medicinal Chemistry Proteomics Annotation of Lipid Rafts Modified by Virus Infection
Combinatorial Chemistry & High Throughput Screening Combined Treatment with PPAR-γ Agonists in Pancreatic Cancer: A Glimmer of Hope for Cancer Therapy?
Current Cancer Drug Targets Recent Patents Reveal Microtubules as Persistent Promising Target for Novel Drug Development for Cancers
Recent Patents on Anti-Infective Drug Discovery The Yin and Yang of CD4+ Regulatory T Cells in Autoimmunity and Cancer
Current Medicinal Chemistry Design, Synthesis and Biological Evaluation of Cyanopyridines, Pyridopyrazolopyrimidines and Pyridopyrazolotriazines as Potential Anticancer Agents
Current Organic Synthesis Destroying RNA as a Therapeutic Approach
Current Medicinal Chemistry In Silico Approaches to the Design of NS5A Inhibitors
Current Topics in Medicinal Chemistry Characterization of Pharmaceutical IgG and Biosimilars Using Miniaturized Platforms and LC-MS/MS
Current Pharmaceutical Biotechnology The Role of Endogenous H2S in Cardiovascular Physiology
Current Pharmaceutical Biotechnology